Heather Larson, PA
Physician Assistant · Orchard Park, NYNPI 1003249269
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 867 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,919, 3.2 times the $1,209 reported in 2021. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 867 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Pfizer$2K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- QOL Medical, LLC$985
- plus $3K from 27 others
What the payments were for
- Food & beverage$13,20699%
- Education$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 130 | $2,547 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 169 | $1,994 |
| Pfizer | 117 | $1,537 |
| Johnson & Johnson(2 entities) | 131 | $1,536 |
| Takeda Pharmaceuticals U.S.A., Inc. | 72 | $1,335 |
| QOL Medical, LLC | 67 | $985 |
| Bristol Myers Squibb | 37 | $474 |
| Lilly USA, LLC | 32 | $441 |
| Ironwood Pharmaceuticals, Inc | 13 | $291 |
| Sanofi | 10 | $276 |
| Intercept Pharmaceuticals, Inc. | 12 | $254 |
| Regeneron Healthcare Solutions, Inc. | 7 | $217 |
| Ardelyx, Inc. | 10 | $207 |
| Phathom Pharmaceuticals, Inc. | 10 | $173 |
| Braintree Laboratories, Inc. | 9 | $163 |
| Ferring Pharmaceuticals Inc. | 5 | $108 |
| Merck | 4 | $87 |
| Exact Sciences | 3 | $75 |
| Novo Nordisk | 4 | $72 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Gilead | 3 | $61 |
| Nestle Healthcare Nutrition Inc. | 3 | $59 |
| Boehringer Ingelheim | 2 | $47 |
| Boston Scientific | 1 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Sandoz | 2 | $38 |
| Redhill Biopharma Inc. | 2 | $37 |
| Alfasigma USA, Inc. | 2 | $28 |
| Amgen | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$13,293 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 33 | $263,054 |
| XifaxanRifaximin | 27 | $74,216 |
| CreonLipase/Protease/Amylase | 39 | $62,045 |
| LinzessLinaclotide | 44 | $50,836 |
| RelistorMethylnaltrexone Bromide | 17 | $48,980 |
| Mesalamine | 42 | $31,824 |
| TrulancePlecanatide | 14 | $19,513 |
| Famotidine | 714 | $14,244 |
| Colestipol Hcl | 60 | $9,437 |
| Dexlansoprazole DrDexlansoprazole | 28 | $9,019 |
| Lubiprostone | 25 | $7,520 |
| Ursodiol | 19 | $7,368 |
| MotegrityPrucalopride Succinate | 11 | $6,313 |
| Esomeprazole Magnesium | 161 | $5,612 |
| Pantoprazole Sodium | 311 | $4,916 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Relistor, Trulance | $1,994 | $142,70958 claims |
| AbbVieCreon, Linzess | $2,547 | $112,88183 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $1,335 | $6,31311 claims |
| SandozLansoprazole | $38 | $2,59087 claims |
| Braintree Laboratories, Inc.Sutab | $163 | $1,75011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Orchard Park
- Jessica AmborskiOrchard Park$27K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.